Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm.

IF 3.8 2区 医学 Q2 PHARMACOLOGY & PHARMACY Drug Metabolism Reviews Pub Date : 2020-11-01 Epub Date: 2020-08-06 DOI:10.1080/03602532.2020.1803907
Hayrunnisa Nadaroglu
{"title":"Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm.","authors":"Hayrunnisa Nadaroglu","doi":"10.1080/03602532.2020.1803907","DOIUrl":null,"url":null,"abstract":"<p><p>The Coronavirus outbreak described as COVID-19 is an insidious and enormous biohazard which began to be noticed in November 2019. When the virus was determined to cause serious upper respiratory tract infections resulting in death, pandemics were declared in the world. As of today, the number of cases exceeded 221 thousand people in Turkey, the number of patients who died had reached 5526. In more than 200 countries around the world, 15.1 million people fight the disease, while the number of people recovered is over 9.134 million, and the number of deaths has exceeded 620 thousand. The top 5 countries in the world are USA, Brazil, Russia, India and Spain. The countries with the highest number of cases after America (approximately 4 million 28 thousand) are Brazil (approximately 2 million 166 thousand), India (about 1 million 195 thousand), Russia (approximately 789 thousand), South Africa (approximately 382 thousand). In addition, the number of deaths and cases caused by Covid 19 continues to increase day by day. In this review, it was aimed to discuss that Covidien-19 against antiviral drugs used in the struggle across the globe and plasma treatment options about the current state of knowledge and Turkey algorithm by comparing the therapeutic treatment options.</p>","PeriodicalId":11307,"journal":{"name":"Drug Metabolism Reviews","volume":"52 4","pages":"531-539"},"PeriodicalIF":3.8000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/03602532.2020.1803907","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03602532.2020.1803907","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2

Abstract

The Coronavirus outbreak described as COVID-19 is an insidious and enormous biohazard which began to be noticed in November 2019. When the virus was determined to cause serious upper respiratory tract infections resulting in death, pandemics were declared in the world. As of today, the number of cases exceeded 221 thousand people in Turkey, the number of patients who died had reached 5526. In more than 200 countries around the world, 15.1 million people fight the disease, while the number of people recovered is over 9.134 million, and the number of deaths has exceeded 620 thousand. The top 5 countries in the world are USA, Brazil, Russia, India and Spain. The countries with the highest number of cases after America (approximately 4 million 28 thousand) are Brazil (approximately 2 million 166 thousand), India (about 1 million 195 thousand), Russia (approximately 789 thousand), South Africa (approximately 382 thousand). In addition, the number of deaths and cases caused by Covid 19 continues to increase day by day. In this review, it was aimed to discuss that Covidien-19 against antiviral drugs used in the struggle across the globe and plasma treatment options about the current state of knowledge and Turkey algorithm by comparing the therapeutic treatment options.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于治疗Covid-19的抗病毒药物和血浆疗法:土耳其全国算法
被称为COVID-19的冠状病毒爆发是一种潜伏的巨大生物危害,于2019年11月开始引起人们的注意。当这种病毒被确定会导致严重的上呼吸道感染并导致死亡时,世界就宣布了大流行。截至今天,土耳其病例数超过22.1万人,死亡人数达到5526人。在全球200多个国家,有1510万人与这种疾病作斗争,治愈人数超过913.4万,死亡人数超过62万。世界上排名前五的国家是美国、巴西、俄罗斯、印度和西班牙。病例数仅次于美国(约42.8万例)的国家是巴西(约216.6万例)、印度(约119.5万例)、俄罗斯(约78.9万例)和南非(约38.2万例)。此外,Covid - 19造成的死亡人数和病例数日益增加。在本文的综述中,旨在通过比较目前各国对Covidien-19抗抗病毒药物的使用情况和血浆治疗方案的认识现状以及土耳其算法的治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Metabolism Reviews
Drug Metabolism Reviews 医学-药学
CiteScore
11.10
自引率
1.70%
发文量
21
审稿时长
1 months
期刊介绍: Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.
期刊最新文献
Role of Herbal Extracts in Modulating Drug Metabolism: Implications for Pharmacokinetics, Enzyme Regulation, and Therapeutic Outcome. Pharmacokinetic considerations and strategies for antibody-based therapeutics. Phase II metabolism in xenobiotic biotransformation: general mechanisms and the underestimated role of microbial systems. An in-depth review of PPARγ modulators as anti-diabetes therapeutics. Traditional Chinese medicine and gut microbiota: biotransformation, interaction, and implications for chronic disease treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1